Patient-derived tumor models are attractive tools to repurpose drugs for ovarian cancer treatment: pre-clinical updates

por Cybula, Magdalena, Bieniasz, Magdalena
Publicado 2022

The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis

por Drumond-Bock, Ana Luiza, Bieniasz, Magdalena
Publicado 2021

Short-form Ron is a novel determinant of ovarian cancer initiation and progression

por Moxley, Katherine M., Wang, Luyao, Welm, Alana L., Bieniasz, Magdalena
Publicado 2016

Cloning BRD4 long isoform into overexpression vectors for stable overexpression of BRD4-L in mammalian cells

por Drumond-Bock, Ana Luiza, Cybula, Magdalena, Wang, Luyao, Wang, Lin, Bieniasz, Magdalena
Publicado 2022

Upregulation of Succinate Dehydrogenase (SDHA) Contributes to Enhanced Bioenergetics of Ovarian Cancer Cells and Higher Sensitivity to Anti-Metabolic Agent Shikonin

por Wang, Lin, Cybula, Magdalena, Rostworowska, Maria, Wang, Luyao, Mucha, Patryk, Bulicz, Magdalena, Bieniasz, Magdalena
Publicado 2022

Multi-kinase targeted therapy as a promising treatment strategy for ovarian tumors expressing sfRon receptor

por Wang, Luyao, Wang, Lin, Cybula, Magdalena, Drumond-Bock, Ana Luiza, Moxley, Katherine M., Bieniasz, Magdalena
Publicado 2020

Increased expression of BRD4 isoforms long (BRD4-L) and short (BRD4-S) promotes chemotherapy resistance in high-grade serous ovarian carcinoma

por Drumond-Bock, Ana Luiza, Wang, Luyao, Wang, Lin, Cybula, Magdalena, Rostworowska, Maria, Kinter, Michael, Bieniasz, Magdalena
Publicado 2023

An unbiased seed-based RNAi selection screen identifies small RNAs that inhibit androgen signaling and prostate cancer cell growth

por Corbin, Joshua M., Georgescu, Constantin, Wang, Lin, Wren, Jonathan D., Bieniasz, Magdalena, Xu, Chao, Asch, Adam S., Ruiz Echevarría, Maria J.
Publicado 2023

Switching the intracellular pathway and enhancing the therapeutic efficacy of small interfering RNA by auroliposome

por Hossen, Md. Nazir, Wang, Lin, Chinthalapally, Harisha R., Robertson, Joe D., Fung, Kar-Ming, Wilhelm, Stefan, Bieniasz, Magdalena, Bhattacharya, Resham, Mukherjee, Priyabrata
Publicado 2020

Targeting BMI1 mitigates chemoresistance in ovarian cancer

por Dey, Anindya, Dhar Dwivedi, Shailendra Kumar, Wang, Lin, Hossen, Md Nazir, Neizer-Ashun, Fiifi, Bieniasz, Magdalena, Mukherjee, Priyabrata, Baird, John D., Weetall, Marla, Bhattacharya, Resham
Publicado 2022

Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research

por Cybula, Magdalena, Wang, Lin, Wang, Luyao, Drumond-Bock, Ana Luiza, Moxley, Katherine M., Benbrook, Doris M., Gunderson-Jackson, Camille, Ruiz-Echevarria, Maria J., Bhattacharya, Resham, Mukherjee, Priyabrata, Bieniasz, Magdalena
Publicado 2021

Gold Nanoparticles Disrupt the IGFBP2/mTOR/PTEN Axis to Inhibit Ovarian Cancer Growth

por Hossen, Md. Nazir, Wang, Lin, Dwivedi, Shailendra Kumar Dhar, Zhang, Yushan, Rao, Geeta, Elechalwar, Chandra Kumar, Sheth, Vinit, Dey, Anindya, Asfa, Sima, Gulla, Suresh Kumar, Xu, Chao, Fung, Kar‐Ming, Robertson, J. David, Bieniasz, Magdalena, Wilhelm, Stefan, Bhattacharya, Resham, Mukherjee, Priyabrata
Publicado 2022